Abstract

BackgroundComorbidity in patients with Rheumatoid Arthritis (RA) is highly prevalent and plays an important role in determining RA related outcomes. Several studies have reported the negative association of comorbidity with...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Physical and Mental Functioning in Patients with Established Rheumatoid Arthritis over an 11-year Followup Period: The Role of Specific Comorbidities.
Gerard J Tijhuis ... Hendriek C Boshuizen
The Journal of rheumatology | VOL. 43
Gerard J Tijhuis, et. al.Gerard J Tijhuis ... Hendriek C Boshuizen
15 Jan 2016
Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis
F C Breedveld
Annals of the Rheumatic Diseases | VOL. 64
F C BreedveldF C Breedveld
29 Jul 2004
Exercise as Medicine in Rheumatoid Arthritis: Effects on Function, Body Composition, and Cardiovascular Disease Risk
George S Metsios ... Andrew Lemmey
Journal of Clinical Exercise Physiology | VOL. 4
George S Metsios, et. al.George S Metsios ... Andrew Lemmey
01 Mar 2015
Long-Term Change and Predictors of Change in Physical and Mental Function after Rehabilitation: A Multi-Centre Study
Geir Egil Eide ... Jan Sture Skouen
Journal of Rehabilitation Medicine | VOL. 55
Geir Egil Eide, et. al.Geir Egil Eide ... Jan Sture Skouen
05 Jan 2023
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers